The Possible Protective Effect of Metformin in COVID-19 Infection

References (31)

1. 1 COVID-19: consider cytokine storm syndromes and immunosuppression [DOI]
2. 2 Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation [DOI]
3. 3 Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor [DOI]
4. 4 Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 [DOI]
5. 5 Tumor Necrosis Factor-α Signaling in Macrophages [DOI]
6. 6 The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7) [DOI]
7. 7 Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status [DOI]
8. 8 Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence [DOI]
9. 9 Update on Neutrophil Function in Severe Inflammation [DOI]
10. 10 Metformin Inhibits the Production of Reactive Oxygen Species from NADH:Ubiquinone Oxidoreductase to Limit Induction of Interleukin-1β (IL-1β) and Boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages [DOI]
11. 11 Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis [DOI]
12. 12 The microgenderome revealed: sex differences in bidirectional interactions between the microbiota, hormones, immunity and disease susceptibility [DOI]
13. 13 AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension [DOI]
14. 14 Metformin and COVID-19: From cellular mechanisms to reduced mortality [DOI]
15. 15 Metformin inhibits HMGB1 release in LPS‐treated RAW 264.7 cells and increases survival rate of endotoxaemic mice [DOI]
16. 16 Circulating angiotensin peptides levels in Acute Respiratory Distress Syndrome correlate with clinical outcomes: A pilot study [DOI]
17. 17 Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review [DOI]
18. 18 ACE2, Metformin, and COVID-19 [DOI]
19. 19 Metformin and COVID‐19: A novel deal of an old drug [DOI]
20. 20 Sexual dimorphism in the mast cell transcriptome and the pathophysiological responses to immunological and psychological stress [DOI]
21. 21 Role of Diabetes in the Development of Acute Respiratory Distress Syndrome* [DOI]
22. 22 Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment [DOI]
23. 23 Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients [DOI]
24. 24 Metformin attenuates myocardial remodeling and neutrophil recruitment after myocardial infarction in rat [DOI]
25. 25 Metformin ameliorates gender-and age-dependent hemodynamic instability and myocardial injury in murine hemorrhagic shock [DOI]
26. 26 Metformin, neutrophils and COVID-19 infection [DOI]
27. 27 Melatonin Potentiates the Therapeutic Effects of Metformin in Women with Metabolic Syndrome [DOI]
28. 28 The effects of metformin on the fibrinolytic system in diabetic and non-diabetic subjects.
29. 29 Capillary endothelia from two ADPKD patients are polyploidy.
30. 30 Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies. [DOI]
31. 31 A proposed mechanism for the possible therapeutic potential of Metformin in COVID-19 [DOI]

Cited by 0

No indexed citations yet.

Related research

• Influence of Vitamin D Level on Diabetic Dyslipidemia — shares topic coverage
• Prevalence of Non-Communicable Diseases in Patients with Type 2 Diabetes Mellitus in Egypt; A Retrospective Survey — shares topic coverage
• No Association between Helicobacter Pylori Infection and Type 2 Diabetes Mellitus; A Case-control Study in the North-Western Part of Ghana — shares topic coverage
• Relationship between Body Mass Index and Low-Density Lipoprotein and Triglycerides in Type 2 Diabetes Mellitus Patients — shares topic coverage
• Clinical Case Series on Assessment of Therapeutic Efficacy of Saroglitazar in MASLD Patients — shares topic coverage